{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:11:56Z","timestamp":1778721116033,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T00:00:00Z","timestamp":1509062400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NCBIR Poland","award":["KB\/88\/12655\/ITT1-C\/U\/08"],"award-info":[{"award-number":["KB\/88\/12655\/ITT1-C\/U\/08"]}]},{"name":"Statutory Activity of Jagiellonian University Medical College","award":["K\/ZDS\/006133"],"award-info":[{"award-number":["K\/ZDS\/006133"]}]},{"name":"Statutory Activity of Jagiellonian University Medical College","award":["K\/ZDS\/006223"],"award-info":[{"award-number":["K\/ZDS\/006223"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s00210-017-1431-y","type":"journal-article","created":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T13:42:19Z","timestamp":1509111739000},"page":"37-49","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Study on the effect of EMD386088, a 5-HT6 receptor partial agonist, in enhancing the anti-immobility action of some antidepressants in rats"],"prefix":"10.1007","volume":"391","author":[{"given":"Magdalena","family":"Jastrz\u0119bska-Wi\u0119sek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"Siwek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Partyka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Ko\u0142aczkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Walczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Smolik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gniewomir","family":"Latacz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Kie\u0107-Kononowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Weso\u0142owska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,27]]},"reference":[{"key":"1431_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1517\/17425255.2.4.629","volume":"2","author":"JJ Cali","year":"2006","unstructured":"Cali JJ, Ma D, Sobol M et al (2006) Luminogenic cytochrome P450 assays. Expert Opin Drug Metab Toxicol 2:629\u2013645. https:\/\/doi.org\/10.1517\/17425255.2.4.629","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"1431_CR2","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00213-010-1798-7","volume":"213","author":"GV Carr","year":"2011","unstructured":"Carr GV, Schechter LE, Lucki I (2011) Antidepressant and anxiolytic effects of selective 5-HT6 receptor agonists in rats. Psychopharmacology 213:499\u2013507. https:\/\/doi.org\/10.1007\/s00213-010-1798-7","journal-title":"Psychopharmacology"},{"key":"1431_CR3","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.mpaic.2014.04.005","volume":"15","author":"K Corrie","year":"2014","unstructured":"Corrie K, Hardman JG (2014) Mechanisms of drug interactions: pharmacodynamics and pharmacokinetics. Anaesth Intensive Care Med 15:305\u2013308. https:\/\/doi.org\/10.1016\/j.mpaic.2014.04.005","journal-title":"Anaesth Intensive Care Med"},{"key":"1431_CR4","doi-asserted-by":"publisher","first-page":"6970","DOI":"10.1021\/jm050529c","volume":"48","author":"G Cruciani","year":"2005","unstructured":"Cruciani G, Carosati E, De Boeck B et al (2005) MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist. J Med Chem 48:6970\u20136979. https:\/\/doi.org\/10.1021\/jm050529c","journal-title":"J Med Chem"},{"key":"1431_CR5","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.neubiorev.2005.03.008","volume":"29","author":"JF Cryan","year":"2005","unstructured":"Cryan JF, Valentino RJ, Lucki I (2005) Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev 29:547\u2013569. https:\/\/doi.org\/10.1016\/j.neubiorev.2005.03.008","journal-title":"Neurosci Biobehav Rev"},{"key":"1431_CR6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0924-977X(99)00034-6","volume":"9","author":"A Daniel","year":"1999","unstructured":"Daniel A, Wojcikowski J (1999) Lysosomal trapping as an important mechanism involved in the cellular distribution of perazine and in pharmacokinetic interaction with antidepressants. Eur Neuropsychopharmacol 9:483\u2013491","journal-title":"Eur Neuropsychopharmacol"},{"key":"1431_CR7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","volume":"121","author":"MJ Detke","year":"1995","unstructured":"Detke MJ, Rickels M, Lucki I (1995) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 121:66\u201372","journal-title":"Psychopharmacology"},{"key":"1431_CR8","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/(SICI)1098-2396(199607)23:3<164::AID-SYN5>3.0.CO;2\u20136","volume":"23","author":"C G\u00e9rard","year":"1996","unstructured":"G\u00e9rard C, el Mestikawy S, Lebrand C et al (1996) Quantitative RT-PCR distribution of serotonin 5-HT6 receptor mRNA in the central nervous system of control or 5,7-dihydroxytryptamine-treated rats. Synapse 23:164\u2013173. https:\/\/doi.org\/10.1002\/(SICI)1098-2396(199607)23:3<164::AID-SYN5>3.0.CO;2\u20136","journal-title":"Synapse"},{"key":"1431_CR9","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.lfs.2009.01.019","volume":"84","author":"K Hirano","year":"2009","unstructured":"Hirano K, Piers TM, Searle KL et al (2009) Procognitive 5-HT6 antagonists in the rat forced swimming test: potential therapeutic utility in mood disorders associated with Alzheimer\u2019s disease. Life Sci 84:558\u2013562. https:\/\/doi.org\/10.1016\/j.lfs.2009.01.019","journal-title":"Life Sci"},{"key":"1431_CR10","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S1734-1140(13)71081-8","volume":"65","author":"M Jastrz\u0119bska-Wi\u0119sek","year":"2013","unstructured":"Jastrz\u0119bska-Wi\u0119sek M, Siwek A, Kazek G et al (2013) Partial agonist efficacy of EMD386088, a 5-HT6 receptor ligand, in functional in vitro assays. Pharmacol Reports 65:998\u20131005","journal-title":"Pharmacol Reports"},{"key":"1431_CR11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.neuropharm.2014.05.036","volume":"85C","author":"M Jastrz\u0119bska-Wi\u0119sek","year":"2014","unstructured":"Jastrz\u0119bska-Wi\u0119sek M, Siwek A, Partyka A et al (2014) Pharmacological evaluation of the anxiolytic-like effects of EMD 386088, a partial 5-HT6 receptor agonist, in the rat elevated plus-maze and Vogel conflict tests. Neuropharmacology 85C:253\u2013262. https:\/\/doi.org\/10.1016\/j.neuropharm.2014.05.036","journal-title":"Neuropharmacology"},{"key":"1431_CR12","doi-asserted-by":"publisher","unstructured":"Jastrz\u0119bska-Wi\u0119sek M, Siwek A, Partyka A et al (2015) Antidepressant-like activity of EMD 386088, a 5-HT6 receptor partial agonist, following systemic acute and chronic administration to rats. Naunyn Schmiedeberg's Arch Pharmacol:2\u201311. https:\/\/doi.org\/10.1007\/s00210-015-1141-2","DOI":"10.1007\/s00210-015-1141-2"},{"key":"1431_CR13","doi-asserted-by":"publisher","unstructured":"Jastrz\u0119bska-Wi\u0119sek M, Siwek A, Partyka A et al (2016) Study of a mechanism responsible for potential antidepressant activity of EMD 386088, a 5-HT6 partial agonist in rats. Naunyn Schmiedeberg's Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-016-1245-3","DOI":"10.1007\/s00210-016-1245-3"},{"key":"1431_CR14","doi-asserted-by":"publisher","first-page":"4230","DOI":"10.1016\/j.bmcl.2005.06.067","volume":"15","author":"C Mattsson","year":"2005","unstructured":"Mattsson C, Sonesson C, Sandahl A et al (2005) 2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists. Bioorg Med Chem Lett 15:4230\u20134234. https:\/\/doi.org\/10.1016\/j.bmcl.2005.06.067","journal-title":"Bioorg Med Chem Lett"},{"key":"1431_CR15","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0026-895X(25)13616-X","volume":"43","author":"FJ Monsma","year":"1993","unstructured":"Monsma FJ, Shen Y, Ward RP et al (1993) Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol Pharmacol 43:320\u2013327","journal-title":"Mol Pharmacol"},{"key":"1431_CR16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00213-011-2297-1","volume":"217","author":"A Nikiforuk","year":"2011","unstructured":"Nikiforuk A, Kos T, Weso\u0142owska A (2011) The 5-HT6 receptor agonist EMD 386088 produces antidepressant and anxiolytic effects in rats after intrahippocampal administration. Psychopharmacology 217:411\u2013418. https:\/\/doi.org\/10.1007\/s00213-011-2297-1","journal-title":"Psychopharmacology"},{"key":"1431_CR17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0026-895X(25)13130-1","volume":"44","author":"JL Plassat","year":"1993","unstructured":"Plassat JL, Amlaiky N, Hen R (1993) Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase. Mol Pharmacol 44:229\u2013236","journal-title":"Mol Pharmacol"},{"key":"1431_CR18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0014-2999(78)90414-4","volume":"51","author":"RD Porsolt","year":"1978","unstructured":"Porsolt RD, Bertin A, Jalfre M (1978) \u201cBehavioural despair\u201d in rats and mice: strain differences and the effects of imipramine. Eur J Pharmacol 51:291\u2013294","journal-title":"Eur J Pharmacol"},{"key":"1431_CR19","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF00492370","volume":"53","author":"A Randrup","year":"1977","unstructured":"Randrup A, Braestrup C (1977) Uptake inhibition of biogenic amines by newer antidepressant drugs: relevance to the dopamine hypothesis of depression. Psychopharmacology 53:309\u2013314","journal-title":"Psychopharmacology"},{"key":"1431_CR20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1006\/bbrc.1993.1619","volume":"193","author":"M Ruat","year":"1993","unstructured":"Ruat M, Traiffort E, Arrang JM et al (1993) A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation. Biochem Biophys Res Commun 193:268\u2013276","journal-title":"Biochem Biophys Res Commun"},{"key":"1431_CR21","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.2147\/DDDT.S116192","volume":"10","author":"B Sadek","year":"2016","unstructured":"Sadek B, Saad A, Latacz G et al (2016) Non-imidazole-based histamine H3 receptor antagonists with anticonvulsant activity in different seizure models in male adult rats. Drug Des Devel Ther 10:3879\u20133898. https:\/\/doi.org\/10.2147\/DDDT.S116192","journal-title":"Drug Des Devel Ther"},{"key":"1431_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1177\/026988119801200201","volume":"12","author":"P Schloss","year":"1998","unstructured":"Schloss P, Williams DC (1998) The serotonin transporter: a primary target for antidepressant drugs. J Psychopharmacol 12:115\u2013121. https:\/\/doi.org\/10.1177\/026988119801200201","journal-title":"J Psychopharmacol"},{"key":"1431_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1472-8206.2004.00195.x","volume":"18","author":"DA Slattery","year":"2004","unstructured":"Slattery DA, Hudson AL, Nutt DJ (2004) Invited review: the evolution of antidepressant mechanisms. Fundam Clin Pharmacol 18:1\u201321. https:\/\/doi.org\/10.1111\/j.1472-8206.2004.00195.x","journal-title":"Fundam Clin Pharmacol"},{"key":"1431_CR24","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/S0149-2918(08)80047-1","volume":"30","author":"E Spina","year":"2008","unstructured":"Spina E, Santoro V, D\u2019Arrigo C (2008) Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. Clin Ther 30:1206\u20131227. https:\/\/doi.org\/10.1016\/S0149-2918(08)80047-1","journal-title":"Clin Ther"},{"key":"1431_CR25","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.1523\/JNEUROSCI.3110-06.2007","volume":"27","author":"P Svenningsson","year":"2007","unstructured":"Svenningsson P, Tzavara ET, Qi H et al (2007) Biochemical and behavioral evidence for antidepressant-like effects of 5-HT6 receptor stimulation. J Neurosci 27:4201\u20134209. https:\/\/doi.org\/10.1523\/JNEUROSCI.3110-06.2007","journal-title":"J Neurosci"},{"key":"1431_CR26","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/S0024-3205(01)01279-6","volume":"69","author":"K Takamori","year":"2001","unstructured":"Takamori K, Yoshida S, Okuyama S (2001) Repeated treatment with imipramine, fluvoxamine and tranylcypromine decreases the number of escape failures by activating dopaminergic systems in a rat learned helplessness test. Life Sci 69:1919\u20131926","journal-title":"Life Sci"},{"key":"1431_CR27","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/S1734-1140(13)71487-7","volume":"65","author":"M Walczak","year":"2013","unstructured":"Walczak M (2013) Binding of new aminopropan-2-ol compounds to bovine serum albumin, \u03b11-acid glycoprotein and rat serum using equilibrium dialysis and LC\/MS\/MS. Pharmacol Rep 65:1294\u20131303","journal-title":"Pharmacol Rep"},{"key":"1431_CR28","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/0306-4522(94)00439-C","volume":"64","author":"RP Ward","year":"1995","unstructured":"Ward RP, Hamblin MW, Lachowicz JE et al (1995) Localization of serotonin subtype 6 receptor messenger RNA in the rat brain by in situ hybridization histochemistry. Neuroscience 64:1105\u20131111. https:\/\/doi.org\/10.1016\/0306-4522(94)00439-C","journal-title":"Neuroscience"},{"key":"1431_CR29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ejphar.2007.11.022","volume":"580","author":"A Weso\u0142owska","year":"2008","unstructured":"Weso\u0142owska A (2008) The anxiolytic-like effect of the selective 5-HT6 receptor antagonist SB-399885: the impact of benzodiazepine receptors. Eur J Pharmacol 580:355\u2013360. https:\/\/doi.org\/10.1016\/j.ejphar.2007.11.022","journal-title":"Eur J Pharmacol"},{"key":"1431_CR30","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.neuropharm.2007.01.007","volume":"52","author":"A Weso\u0142owska","year":"2007","unstructured":"Weso\u0142owska A, Nikiforuk A (2007) Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression. Neuropharmacology 52:1274\u20131283. https:\/\/doi.org\/10.1016\/j.neuropharm.2007.01.007","journal-title":"Neuropharmacology"},{"key":"1431_CR31","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/FBP.0b013e3282d28f9c","volume":"18","author":"A Weso\u0142owska","year":"2007","unstructured":"Weso\u0142owska A, Nikiforuk A, Stachowicz K (2007) Anxiolytic-like and antidepressant-like effects produced by the selective 5-HT6 receptor antagonist SB-258585 after intrahippocampal administration to rats. Behav Pharmacol 18:439\u2013446. https:\/\/doi.org\/10.1097\/FBP.0b013e3282d28f9c","journal-title":"Behav Pharmacol"},{"key":"1431_CR32","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/S0024-3205(98)00092-7","volume":"62","author":"M Yoshioka","year":"1998","unstructured":"Yoshioka M, Matsumoto M, Togashi H et al (1998) Central distribution and function of 5-HT6 receptor subtype in the rat brain. Life Sci 62:1473\u20131477. https:\/\/doi.org\/10.1016\/S0024-3205(98)00092-7","journal-title":"Life Sci"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-017-1431-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-017-1431-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-017-1431-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T19:34:06Z","timestamp":1750966446000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-017-1431-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,27]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["1431"],"URL":"https:\/\/doi.org\/10.1007\/s00210-017-1431-y","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,27]]}}}